A detailed history of Exane Derivatives transactions in Raymond James Financial Inc stock. As of the latest transaction made, Exane Derivatives holds 1,130 shares of RJF stock, worth $133,204. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,130
Previous 2,647 57.31%
Holding current value
$133,204
Previous $290,000 65.17%
% of portfolio
0.06%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$85.45 - $113.79 $129,627 - $172,619
-1,517 Reduced 57.31%
1,130 $101,000
Q1 2022

Apr 22, 2022

BUY
$92.96 - $115.44 $130,701 - $162,308
1,406 Added 113.3%
2,647 $290,000
Q4 2021

Jan 28, 2022

SELL
$93.38 - $102.53 $20,450 - $22,454
-219 Reduced 15.0%
1,241 $124,000
Q3 2021

Oct 26, 2021

BUY
$82.69 - $95.33 $80,374 - $92,660
972 Added 199.18%
1,460 $134,000
Q2 2021

Jul 28, 2021

BUY
$82.71 - $91.09 $40,362 - $44,451
488 New
488 $42,000

Others Institutions Holding RJF

About RAYMOND JAMES FINANCIAL INC


  • Ticker RJF
  • Exchange NYSE
  • Sector Financial Services
  • Industry Capital Markets
  • Shares Outstandng 215,100,000
  • Market Cap $25.4B
  • Description
  • Raymond James Financial, Inc., a diversified financial services company, provides private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities in the United States, Canada, and Europe. The Private Client Group segment offers investment services, portfolio management service...
More about RJF
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.